Immune Impact Induced by PROSTVAC (PSA-TRICOM), a Therapeutic Vaccine for Prostate Cancer

PSA-TRICOM (PROSTVAC) is a novel vector-based vaccine designed to generate a robust immune response against prostate-specific antigen (PSA)–expressing tumor cells. The purpose of this report is to present an overview of both published studies and new data in the evaluation of immune responses to the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Gulley, James L., Madan, Ravi A., Tsang, Kwong Y., Jochems, Caroline, Marté, Jennifer L., Farsaci, Benedetto, Tucker, Jo A., Hodge, James W., Liewehr, David J., Steinberg, Seth M., Heery, Christopher R., Schlom, Jeffrey
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4004961/
https://ncbi.nlm.nih.gov/pubmed/24778277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-13-0108
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars